Ask4UFE has announced the #LoveYourUterus campaign to encourage women with painful fibroids to share their stories of health and healing. Uterine fibroids often result in women having hysterectomies because they are unaware of uterine fibroid embolization (UFE), which is a less invasive procedure.
Oxygen therapy, Granulox (inFirst Healthcare), has been shown to be an effective, safe and easy-to-use treatment, according to a new study published in the recent edition of Diabetic Foot and Ankle Journal.
Modulated Imaging has received clearance from the US Food and Drug Administration (FDA) for its Ox-Imager CS technology. This device is designed to assist clinicians with the identification of lower limb vascular issues, so that patients can receive appropriate, timely treatment.
Endologix has resumed shipments of all sizes of AFX2 endovascular abdominal aortic aneurysm systems. The large diameter sizes of AFX2 were placed on a temporary hold on 27 December, 2016, to investigate a manufacturing issue. Since the hold, the company has been working on process improvements and developed additional testing protocols that have been reviewed by US Food and Drug Administration (FDA). Shipments of the larger sizes of AFX2 resumed on 17 January.
Intact Vascular has attained the CE mark for the Tack endovascular system for the repair of arterial dissections following percutaneous transluminal angioplasty (PTA) below the knee. This extended indication in the European Union enables the use of the Tack system in the tibial arteries between the knee and ankle.
Updated European Society for Vascular Surgery (ESVS) clinical practice guidelines regarding the management of diseases of the descending thoracic aorta have been published in the European Journal of Vascular and Endovascular Surgery.
Due to its two-dimensional (2D) nature and the high radiation exposure associated with its use, fluoroscopy is an imperfect solution to endovascular surgery’s need for intraoperative imaging. At the 2016 VEITHsymposium (15–19 November, New York, USA), Matthew Eagleton, Cleveland Clinic, Cleveland, USA, presented his centre’s initial experiences with the Intraoperative Positioning System (IOPS; Centerline Biomedical), suggesting that it may represent an opportunity to transition away from fluoroscopy.
The Society for Vascular Surgery (SVS) and the Society for Vascular Nursing (SVN) have issued a statement encouraging vascular surgery teams to actively assist smokers with smoking cessation before surgery.
Current Intact Vascular investors—New Enterprise Associates, Quaker Partners and HIG BioHealth Partners—have exercised their right to invest additional capital as part of the company’s Series B financing, bringing the total raised to US$46m after the financing initially closed in May 2015. The funds will be used to advance the company’s clinical development programme, encompassing both above-the-knee and below-the-knee clinical trials, as well as product development initiatives aimed at expanding the utility of the Tack endovascular system for the treatment of peripheral artery disease.
Abbott has now completed the acquisition of St Jude Medical. The Abbott press release announcing the completion of the acquisition said, “The transaction provides Abbott with expanded opportunities for future growth and is an important part of the company’s ongoing effort to develop a strong, diverse portfolio of devices, diagnostics, nutritionals and branded generic pharmaceuticals.”
The use of hypnosis during endovascular aneurysm repair (EVAR) may improve haemodynamic and respiratory stability and allow faster patient recovery, according to a presentation given at the 2016 VEITHsymposium (15–19 November, New York, USA).
The EVAR 1 trial—investigating the efficacy of endovascular aneurysm repair (EVAR) versus open repair—and the ENGAGE registry—examining the performance of the Endurant (Medtronic) stent graft—are two or the largest EVAR trials conducted to date. In a comparison of their data at the 2016 VEITHsymposium (15–19 November, New York, USA), Dittmar Böckler (University of Heidelberg, Heidelberg, Germany) told delegates that newer generation devices should use EVAR 1 data to benchmark future clinical performance, while the ENGAGE registry demonstrates how technical evolution has already contributed to improved patient outcomes.
Endologix has issued a letter to physicians with updated information about the AFX endovascular abdominal aortic aneurysm system.
Humacyte has announced the initiation of a US phase II arterial bypass clinical trial of Humacyl, an investigational human acellular vessel, to test its safety and efficacy as a lower extremity arterial bypass vessel in patients with peripheral artery disease.
Avinger has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Lightbox L250 imaging console. Avinger says that with this new FDA clearance, the Lightbox L250 now provides detailed measurement of vessels using a touch screen, helping improve visualisation inside the vessel before, during, and after Pantheris Lumivascular atherectomy procedures for the treatment of peripheral artery disease.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos